Technical Specifications
| Drug Composition | Regorafenib 40 mg Tablets |
|---|---|
| Variant / Strength | 40 mg |
| Dosage Form / Type | Tablets |
| Product Benefits | Cancer of colon and rectum |
| Packaging Type | Bottle |
| Delivery Time | 7 - 15 Days, as per delivery location. |
| Country of Origin | Made in India |
| Export Destinations | USA, UK, UAE, Philippines, Thailand, Kenya, Nigeria, Germany, Canada, Mexico, and 65+ more countries |
| Export Route | Shipped via temperature-controlled international air courier with full customs documentation |
Product Overview & Description
Regorafenib 40 mg Tablets, a Tyrosine kinase inhibitor, is utilized in the treatment of colorectal cancer /cancer of colon and rectum.
For optimal benefits, Regorafenib 40 mg Tablets should be taken with food, consistently at the same time each day. The doctor determines the necessary dosage and frequency based on the patient's specific condition, which may change over time. Strict adherence to the doctor's instructions is crucial to avoid serious side effects. While the benefits may take weeks or months to become apparent, discontinuation should only occur under the doctor's guidance.
Submit Quotation Request
Verified Customer Reviews (0)
Frequently Asked Questions
ℹ️ Information reviewed by Medibliss Lifesciences Editorial Team. Last reviewed: August 2026. Data sourced from manufacturer documentation and WHO-GMP certificates.
Disclaimer: The information provided on this page is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Medibliss Lifesciences acts solely as an exporter and supplier. Please consult your physician or a qualified healthcare provider before starting any medication. We do not manufacture these products and rely on the manufacturer's provided documentation and WHO-GMP certifications for product information.